June 15, 2024
Bruxism Treatment Market

Bruxism Treatment Is Expected To Be Flourished By Growing Prevalence Of Stress And Anxiety

Bruxism, commonly known as teeth grinding, is a condition in which a person grinds their teeth or clenches their jaws. It mainly occurs during sleep, but sometimes during periods of concentration or stress while awake. Bruxism treatment involves the use of mouth guards, botox injection in jaw muscles, and medications to relax the jaw muscles. Mouth guards are custom-made dental appliances that are worn either during sleep or while awake, to prevent grinding and relieve pain and damage caused by excessive teeth clenching or grinding.

The global bruxism treatment market is estimated to be valued at US$ 1403.76 Bn  in 2024 and is expected to exhibit a CAGR of 11%  over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Stress and anxiety are major triggers for bruxism as they cause muscle tension in the jaw. With rising stress levels owing to changing lifestyles and increasing workload, the prevalence of stress and anxiety related disorders has grown substantially over the past few years. According to the National Institute of Mental Health, over 40 million American adults experience some form of anxiety disorders every year. The growing patient pool of stress and anxiety disorders is expected to drive the demand for effective bruxism treatment solutions.

Market Dynamics:

Growing Prevalence of Stress and Anxiety (refered from heading)- Stress and anxiety are key lifestyle diseases witnessed worldwide due to changing lifestyles and rapid urbanization. Per the WHO, stress and anxiety disorders are among the leading causes of disease burden globally. About 264 million people are estimated to suffer from anxiety disorders according to the Anxiety and Depression Association of America. High levels of stress put extra tension on jaw muscles which in turn increases the likelihood of teeth grinding. The rising stress pandemic is anticipated to fuel the incidence of bruxism, thereby driving the bruxism treatment market during the forecast period.

Availability of Varied Treatment Options- Multiple treatment options available including dental splints, mouth guards, Botox injections, and medications provide relief from different symptoms of bruxism. While mouthpieces and dental splints protect teeth from damage, Botox targets muscle activity and relaxing medicines alleviate jaw tension and excessive clenching. The diversity of treatment choices catering to varying patient needs and preferences increases the potential customer base for bruxism treatment providers.

Segment Analysis

The Bruxism Treatment Market Growth can be segmented into two major types – bruxism appliances and bruxism medicine. Bruxism appliances dominates the market with a share of over 65% as it offers a effective long-term solution to bruxism. Bruxism appliances are further segmented into mouth guards, anti-snoring devices, and other appliances. Mouth guards dominate this segment due to their ability to protect teeth from damage caused due to teeth grinding.

PEST Analysis

Political: There are no major political influences affecting the bruxism treatment market.

Economic: The increasing prevalence of stress and bruxism disorders globally is driving market growth. Rising healthcare spending in developing countries also supports market expansion.

Social: Growing awareness about bruxism and available treatment options is encouraging people to seek medical help. Increasing consumption of caffeine and alcohol which are bruxism triggers also influence the market.

Technological: Advancements in materials for bruxism appliances allow customized fitting and greater comfort. Development of integrated sensors in these devices to monitor bruxism severity helps clinicians evaluate treatment effectiveness.

Key Takeaways

The global bruxism treatment market is expected to witness high growth over the forecast period. The global bruxism treatment market is estimated to be valued at US$ 1403.76 Bn  in 2024 and is expected to exhibit a CAGR of 11%  over the forecast period 2024 to 2031.

North America dominates currently due to high awareness levels and availability of advanced treatment options in the region. However, Asia Pacific is expected to witness the fastest growth on account of rising bruxism cases attributed to changing lifestyles in the region and growing medical tourism.

Key players operating in the bruxism treatment market are Siemens Healthcare Private Limited, Pfizer Inc., Ivoclar Vivadent AG, GlaxoSmithKline plc, and Ipsen Pharma. These players focus on new product launches and strategic collaborations with dental clinics and hospitals to strengthen their presence.

1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it